HR 716 111th Congress House Health Cancer Drug therapy Employee benefits and pensions Government studies and investigations Health care costs and insurance Health care coverage and access Medical research

Access to Cancer Clinical Trials Act of 2009

Introduced: January 27, 2009 See on congress.gov

Everywhere this bill has been 6 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jan 28, 2009

Referred to the Subcommittee on Health.

Jan 27, 2009

Referred to House Ways and Means

Jan 27, 2009

Referred to House Education and Labor

Jan 27, 2009

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Labor, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Jan 27, 2009

Referred to House Energy and Commerce

Jan 27, 2009

Introduced in House

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

Plain-English summary Congressional Research Service

Access to Cancer Clinical Trials Act of 2009 - Amends the Public Health Service Act, the Employee Retirement Income Security Act of 1974 (ERISA), and the Internal Revenue Code to prohibit a group health plan from: (1) denying an eligible participant or beneficiary participation in clinical trials related to the treatment of cancer that are federally funded or conducted under an investigational new drug application reviewed by the Food and Drug Administration (FDA); (2) denying (or limiting or imposing additional conditions on) the coverage of routine patient costs for items and services furnished in connection with such participation; or (3) discriminating against an individual on the basis of such participation. Includes as routine patient costs all items and services provided in the clinical trial that are otherwise generally available to a qualified individual, with certain exceptions.

Applies such prohibitions to coverage offered in the individual market.

Requires the Secretary of Health and Human Services to study the impact on group health plans and health insurance issuers of requiring them to cover routine patient care costs for individuals with serious and life threatening diseases other than cancer.

What's happening now January 28, 2009

Referred to the Subcommittee on Health.

Related & companion bills 1

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 4

Education and Workforce Committee
House of Representatives
Energy and Commerce Committee
House of Representatives
Health Subcommittee
House of Representatives · subcommittee of Energy and Commerce Committee
Ways and Means Committee
House of Representatives

Cosponsors 10

Titus, Dina

Nevada · May 26, 2010

Sánchez, Linda T.

California · Feb 24, 2010

Baldwin, Tammy

Wisconsin · Sep 24, 2009

Cohen, Steve

Tennessee · Jun 19, 2009

Wasserman Schultz, Debbie

Florida · Mar 26, 2009

Lofgren, Zoe

California · Mar 11, 2009

Kaptur, Marcy

Ohio · Mar 4, 2009

Nadler, Jerrold

New York · Feb 11, 2009

Carson, André

Indiana · Feb 9, 2009

Schakowsky, Janice D.

Illinois · Feb 9, 2009

Cite this page click to expand

APA

U.S. Congress. (2026). H.R. 716: Access to Cancer Clinical Trials Act of 2009. 111th Congress. Open America. https://openamerica.io/bill/111-HR-716/

MLA

"H.R. 716: Access to Cancer Clinical Trials Act of 2009." 111th Congress, 2026, Open America, https://openamerica.io/bill/111-HR-716/.

Bluebook (legal)

H.R. 716, 111th Cong. (2026), https://openamerica.io/bill/111-HR-716/.

Markdown link

[H.R. 716: Access to Cancer Clinical Trials Act of 2009](https://openamerica.io/bill/111-HR-716/)